Xenetic Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Xenetic Biosciences Stock Summary

Xenetic Biosciences competes with Transcode Therapeutics, ZyVersa Therapeutics, Immix Biopharma, Phio Pharmaceuticals, and 180 Life. Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell platform technology engineered to target patient-specific tumor neoantigens. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Xenetic Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Xenetic Biosciences Key Financial Ratios

Xenetic Biosciences Key Balance Sheet Accounts

Xenetic Biosciences Key Income Statement Accounts

Xenetic Biosciences Key Cash Accounts

Xenetic Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Xenetic Biosciences's current stock value. Our valuation model uses many indicators to compare Xenetic Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xenetic Biosciences competition to find correlations between indicators driving Xenetic Biosciences's intrinsic value. More Info.Xenetic Biosciences is rated second in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Xenetic Biosciences' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xenetic Biosciences' earnings, one of the primary drivers of an investment's value.

Xenetic Biosciences Systematic Risk

Today, most investors in Xenetic Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Xenetic Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Xenetic Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Xenetic Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Xenetic Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Xenetic Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Xenetic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Xenetic Biosciences's daily price indicators and compare them against related drivers.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenetic Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenetic Biosciences. If investors know Xenetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenetic Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Xenetic Biosciences is measured differently than its book value, which is the value of Xenetic that is recorded on the company's balance sheet. Investors also form their own opinion of Xenetic Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Xenetic Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenetic Biosciences' market value can be influenced by many factors that don't directly affect Xenetic Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Xenetic Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenetic Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenetic Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.